KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Share-based Compensation (2017 - 2026)

Cardlytics filings provide 10 years of Share-based Compensation readings, the most recent being $4.8 million for Q1 2026.

  • Quarterly Share-based Compensation fell 44.47% to $4.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.3 million through Mar 2026, down 36.28% year-over-year, with the annual reading at $28.1 million for FY2025, 30.32% down from the prior year.
  • Share-based Compensation hit $4.8 million in Q1 2026 for Cardlytics, down from $5.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $13.6 million in Q1 2022 and bottomed at $4.8 million in Q1 2026.
  • Average Share-based Compensation over 5 years is $9.4 million, with a median of $8.7 million recorded in 2025.
  • Peak annual rise in Share-based Compensation hit 87.43% in 2022, while the deepest fall reached 65.73% in 2022.
  • Cardlytics' Share-based Compensation stood at $12.5 million in 2022, then dropped by 11.75% to $11.0 million in 2023, then fell by 21.33% to $8.7 million in 2024, then plummeted by 36.45% to $5.5 million in 2025, then fell by 12.41% to $4.8 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Share-based Compensation are $4.8 million (Q1 2026), $5.5 million (Q4 2025), and $6.4 million (Q3 2025).